Highlights of the important and interesting in the world of healthcare:
Defunding, implementation biggest reform threats. Defunding by Congress and implementation by governors are the two major threats facing healthcare reform, Tom Daschle, former U.S. Senate majority leader who almost became Department of Health and Human Services nomination in the Obama administration, tells Kaiser Health News.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Flu shots pit doctors against pharmacists. As pharmacies in Metro Detroit pump up their efforts to administer flu vaccinations, Michigan doctors complain they receive the vaccine after the drug stores do, according to the Detroit News.
Patent cliff causes Eli Lilly grief. Indianapolis drug maker Eli Lilly & Co. got an earful from securities analysts Thursday about what it should do to survive a huge revenue fall-off in coming years when its drug development pipeline slows to a trickle, reports the Indianapolis Star. That despite beating Wall Street earnings estimates, the New York Times said.
Quintiles to run ‘technology cloud’ from India. Quintiles, the leading U.S. bio pharmaceuticals contract research organization in Durham, North Carolina, has opened its Global Information Technology Service Operations Center in Bangalore, India, which “provides intelligent monitoring, control and triage of system events across Quintiles’ technology cloud.”
Avandia hurts GlaxoSmithKline. The loss of the blockbuster diabetes drug Avandia and reforms to U.S. and European healthcare programs prompted a 5 percent decline in third-quarter pretax profit at GlaxoSmithKline, according to the Financial Times.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
UnitedHealth to pay fees to cancer doctors. UnitedHealth Group Inc., the biggest U.S. health insurer by sales, will pay cancer doctors a fee to stop marking up the prices of drugs in a test aimed at reducing costs for medical plans and their customers, Bloomberg reports.
